480 related articles for article (PubMed ID: 15959668)
1. The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies.
Dalakas MC
J Neurol; 2005 May; 252 Suppl 1():I19-25. PubMed ID: 15959668
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies: effects on clinicopathological features and immunoregulatory genes.
Dalakas MC
Clin Rev Allergy Immunol; 2005 Dec; 29(3):255-69. PubMed ID: 16391401
[TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous immune globulin for stiff-person syndrome.
Dalakas MC; Fujii M; Li M; Lutfi B; Kyhos J; McElroy B
N Engl J Med; 2001 Dec; 345(26):1870-6. PubMed ID: 11756577
[TBL] [Abstract][Full Text] [Related]
4. Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects.
Dalakas MC
J Neurol; 2006 Sep; 253 Suppl 5():V25-32. PubMed ID: 16998751
[TBL] [Abstract][Full Text] [Related]
5. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.
Rakocevic G; Raju R; Dalakas MC
Arch Neurol; 2004 Jun; 61(6):902-4. PubMed ID: 15210528
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
7. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.
Ali F; Rowley M; Jayakrishnan B; Teuber S; Gershwin ME; Mackay IR
J Autoimmun; 2011 Sep; 37(2):79-87. PubMed ID: 21680149
[TBL] [Abstract][Full Text] [Related]
8. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
Baizabal-Carvallo JF
J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
[TBL] [Abstract][Full Text] [Related]
9. [Stiff-person syndrome and other myelopathies constitute paraneoplastic neurological syndromes].
Ishii A
Brain Nerve; 2010 Apr; 62(4):377-85. PubMed ID: 20420178
[TBL] [Abstract][Full Text] [Related]
10. Long-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody-Positive Stiff-Person Syndrome.
Yi J; Dalakas MC
Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35798561
[TBL] [Abstract][Full Text] [Related]
11. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies.
Dalakas MC; Li M; Fujii M; Jacobowitz DM
Neurology; 2001 Sep; 57(5):780-4. PubMed ID: 11552003
[TBL] [Abstract][Full Text] [Related]
12. Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.
Chang T; Alexopoulos H; McMenamin M; Carvajal-González A; Alexander SK; Deacon R; Erdelyi F; Szabó G; Lang B; Blaes F; Brown P; Vincent A
JAMA Neurol; 2013 Sep; 70(9):1140-9. PubMed ID: 23877118
[TBL] [Abstract][Full Text] [Related]
13. Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature.
Jazebi N; Rodrigo S; Gogia B; Shawagfeh A
J Neuroimmunol; 2019 Jul; 332():135-137. PubMed ID: 31015081
[TBL] [Abstract][Full Text] [Related]
14. Qualitative and quantitative evidence of anti-glutamic acid decarboxylase-specific intrathecal antibody synthesis in patients with stiff person syndrome.
Jarius S; Stich O; Speck J; Rasiah Ch; Wildemann B; Meinck HM; Rauer S
J Neuroimmunol; 2010 Dec; 229(1-2):219-24. PubMed ID: 20813415
[TBL] [Abstract][Full Text] [Related]
15. Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies.
Dalakas MC
Neurotherapeutics; 2022 Apr; 19(3):832-847. PubMed ID: 35084720
[TBL] [Abstract][Full Text] [Related]
16. Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment.
Petrijan T; Menih M
Cerebellum; 2017 Aug; 16(4):868-871. PubMed ID: 28321713
[TBL] [Abstract][Full Text] [Related]
17. Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies.
Rakocevic G; Raju R; Semino-Mora C; Dalakas MC
Neurology; 2006 Sep; 67(6):1068-70. PubMed ID: 17000981
[TBL] [Abstract][Full Text] [Related]
18. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome.
Dalakas MC; Fujii M; Li M; McElroy B
Neurology; 2000 Nov; 55(10):1531-5. PubMed ID: 11094109
[TBL] [Abstract][Full Text] [Related]
19. [Stiff-person syndrome and other neurological disorders associated with anti-GAD antibodies].
Hijazi J; Bedat-Millet AL; Hannequin D
Rev Med Interne; 2010 Jan; 31(1):23-8. PubMed ID: 19828214
[TBL] [Abstract][Full Text] [Related]
20. Severe Stiff-Person Syndrome After COVID: The First Video-Documented COVID Exacerbation and Viral Implications.
Dalakas MC
Neurol Neuroimmunol Neuroinflamm; 2024 Mar; 11(2):e200192. PubMed ID: 38147623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
